US20030129186A1 - Compositions and methods for modulating blood-brain barrier transport - Google Patents

Compositions and methods for modulating blood-brain barrier transport Download PDF

Info

Publication number
US20030129186A1
US20030129186A1 US10/206,448 US20644802A US2003129186A1 US 20030129186 A1 US20030129186 A1 US 20030129186A1 US 20644802 A US20644802 A US 20644802A US 2003129186 A1 US2003129186 A1 US 2003129186A1
Authority
US
United States
Prior art keywords
p97
mtf
method
receptor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/206,448
Inventor
Richard Beliveau
Michel Demeule
Joseph Yang
Malcolm Kennard
Reinhard Gabathuler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Horizon Orphan LLC
Original Assignee
BioMarin Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US30800201P priority Critical
Application filed by BioMarin Pharmaceutical Inc filed Critical BioMarin Pharmaceutical Inc
Priority to US10/206,448 priority patent/US20030129186A1/en
Assigned to BIOMARIN PHARMACEUTICAL, INC. reassignment BIOMARIN PHARMACEUTICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KENNARD, MALCOLM L., YANG, JOSEPH, GABATHULER, REINHARD, DEMEULE, MICHEL, BELIVEAU, RICHARD
Publication of US20030129186A1 publication Critical patent/US20030129186A1/en
Assigned to RAPTOR PHARMACEUTICAL INC. reassignment RAPTOR PHARMACEUTICAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOMARIN PHARMACEUTICAL INC.
Assigned to RAPTOR DISCOVERIES INC. reassignment RAPTOR DISCOVERIES INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: RAPTOR PHARMACEUTICAL INC.
Assigned to RAPTOR PHARMACEUTICALS INC. reassignment RAPTOR PHARMACEUTICALS INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: RAPTOR DISCOVERIES INC.
Assigned to HORIZON ORPHAN LLC reassignment HORIZON ORPHAN LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: RAPTOR PHARMACEUTICALS INC.
Application status is Abandoned legal-status Critical

Links